New York City, NY: Jun 19, 2019 – Published via (Wired Release) – Insulin delivery system use for administration of insulin through the skin and into the fatty tissue below the skin. Insulin delivery systems includes insulin pen, insulin pump, insulin syringe, insulin jet injector, and insulin inhaler. Innovations in insulin delivery systems include, pens that are easy to handle and use, can measure blood glucose level, and keep track of insulin doses. Also, manufacturers are now focusing on developing needle free insulin delivery systems that reduce chances of needle stick injuries and also help those people who have syringe phobia.
The first five-year cumulative revenue (2017–2021) is projected to be US$ 66,394.1 Mn, which is expected to increase rather moderately over the latter part of the five-year forecast period. According to report, the insulin delivery systems market is projected to reach a value of over US$ 22,511.8 Mn in 2026 at a CAGR of 7.8% over the forecast period.
High prevalence rate coupled with increasing incidence of diabetes in developed as well as in developing countries, coupled with growing awareness among individuals abut use of insulin delivery systems are major factors driving growth of the global insulin delivery systems market. In addition, increasing government initiatives for spreading awareness about diabetes, availability of various insulin delivery systems, and growing adoption of insulin delivery systems by households across developed and developing economies are other major factors expected to fuel growth of the global insulin delivery systems market over the forecast period.
Request For Sample Report Before Buying (Use Corporate eMail ID to Get Higher Priority): https://marketresearch.biz/report/insulin-delivery-system-market/request-sample/
Global Insulin Delivery Systems Market: Market Forecast
The comprehensive research report comprises a complete forecast of the global insulin delivery systems market based on factors affecting the market and their impact in the foreseeable future. According to the forecast projections, revenue from the global insulin delivery systems market is expected to expand at a moderate CAGR of 7.8% during the forecast period.
Global Insulin Delivery Systems Market: Segmental Snapshot
The market report has been segmented on the basis of product, distribution channel, and region. The product segment includes insulin pen, insulin pump, insulin syringe, and others. The distribution channel segment includes hospitals, diabetes specialty clinics, and retail channels. The regions covered in the analysis are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
By product: The insulin pen segment accounted for highest revenue share contribution as compared to that of the insulin pump, insulin syringe, and others. The insulin pump segment is expected to register a CAGR of over 8.0% between 2017 and 2026.
By distribution channel: The hospitals segment is estimated to register highest CAGR of 7.8% as compared to that of the other end user segments. Also, it is projected to account for a dominant revenue share in the global insulin delivery systems market over the forecast period.
By region: The market in North America accounted for highest revenue share in the global insulin delivery systems market in 2016, and is expected to register a CAGR of over 7.0% between 2017 and 2026.
Inquire for Further Detailed Information About The Report Before Buying (Use Corporate email ID to Get Higher Priority): https://marketresearch.biz/report/insulin-delivery-system-market/#inquiry
Global Insulin Delivery Systems Market: Competitive Analysis
The research report on the global insulin delivery systems market includes profiles of some of major companies such as Becton, Dickinson and Company, Eli Lilly and Company, Medtronic plc, Sanofi, F. Hoffmann-La Roche Ltd., Cellnovo Limited, Insulet Corporation, Tandem Diabetes Care, Inc., Companion Medical, Inc., and Copernicus Sp. z o.o.
Pricing Details For The Report: (Limited Period Offer) Single User- $3,995 | Multiple User- $6,600 | Corporate Users- $8,200
To Purchase This Premium Report Click Here: https://marketresearch.biz/purchase-report/?report_id=587
How do Single user, multiple user, and corporate licenses differ from each other?
Single user, multiple user, and corporate licenses are differentiated on the basis of the number of users permitted to use the ordered reports. For a single user license, the distribution of a report copy will be restricted to only one user. Understood by its term, a multiple user license will be restricted to more than one user, typically five users only. Corporate license holders, on the other hand, will be able to distribute a report copy across their organization.
About Us:
MarketResearch.Biz is a specialized market research, analytics, and solutions company, offering strategic and tactical support to clients for making well-informed business decisions. We are a team of dedicated and impassioned individuals, who believe strongly in giving our very best to what we do and we never back down from any challenge. It offers services such as data mining, information management, and revenue enhancement solutions and suggestions.
Contact Us:
Mr. Benni Johnson
Prudour Pvt. Ltd.
420 Lexington Avenue,
Suite 300 New York City, NY 10170,
United States
Tel: + 1-347-826-1876
Email ID: inquiry@marketresearch.biz
Website: https://marketresearch.biz/
from Wired Release http://bit.ly/31H8Gk4
via gqrds
No comments:
Post a Comment